Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

2.

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

3.

Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

4.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

5.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot